Reckitt Benckiser

Move Free Glucosamine, along with AARP, objected — as amici curiae — to a class-action settlement that sought to resolve claims filed against Schiff Nutrition for deceptively marketing Move Free® Advanced glucosamine supplements as “clinically tested” and able to rebuild joint cartilage, improve joint function, and reduce joint pain, when there was no competent scientific evidence to support such marketing claims.


  • Filed objection to settlement along with AARP
  • Parties revised settlement agreement
  • Court agreed with regarding value of injunctive relief and lowered attorney’s fees


November 3

The Court issues its official Order granting final approval of the settlement.

October 30

The Court holds a final fairness hearing and grants final approval of the settlement agreement, but lowers the amount of attorney’s fees the plaintiffs counsel will receive from 33% of the settlement fund to 25% of the fund, as advocated by and AARP.

October 13 and AARP file a reply brief.

October 8

Plaintiffs and defendants file responses to objections to the proposed settlement agreement.

May 8 and AARP file a supplemental brief opposing the parties’ proposed revisions to the settlement agreement.

April 27

One month after the Court grants’s Motion for Leave, the parties file a joint motion to modify the proposed settlement agreement.  Among the minor changes made to the agreement, the parties have agreed to ban the same six specific phrases as before (“repair joints,” “repair cartilage,” “rebuild joints,” “rebuild cartilage,” “rejuvenate joints,” or “rejuvenate cartilage”) from the labeling and marketing of the supplements, but are now also banning “any version of those statements using variations of the proscribed terms (e.g., ‘repairs,’ ‘rebuilding,’ ‘rejuvenation,’ etc.).”  The injunctive relief still does not expand to synonymous language and still expires after two years.

March 26

The Court grants’s and AARP’s Motion for Leave to file their opposition to the proposed settlement, and denies plaintiffs’ motion to withdraw.

March 11 and AARP file a brief as amici curiae opposing the proposed settlement reached by the parties, as well as a Motion for Leave to file the brief.

March 2

Plaintiffs reply to defendants’ objection.

February 23

Defendants object to plaintiffs’ motion to withdraw.

February 6

In anticipation of’s objection, plaintiffs try to withdraw from proposed settlement agreement.

March 25

Plaintiffs move for preliminary approval of a settlement agreement.


Plaintiffs file a class-action complaint against Schiff Nutrition International, which was later amended.

* The above events do not represent the entire procedural history of the case, but rather only highlights some key events pertaining to’s involvement in the case.


The Latest


Class-Action Tracker

Move Free Glucosamine Supplements

Class Action

Move Free Glucosamine Supplements

Allegations: Falsely advertising that Move Free provides joint health benefits when the ingredients in the supplement do not provide such benefits

Schiff Move Free® Advanced

Class Action

Schiff Move Free® Advanced

May 2016: The appeal was voluntarily dismissed When a complaint is dismissed with prejudice, it cannot be refiled.. The reasons have not been disclosed. November 2015: A federal judge granted…

Move Free® Supplements

Class Action

Move Free® Supplements

August 2016: This action was dismissed When a complaint is dismissed with prejudice, it cannot be refiled. because the claims were resolved pursuant to a settlement in another case, Lerma…

Move Free®

Class Action

Move Free®

November 2015: After the settlement in the Lerma case was approved in October 2015, this lawsuit was dismissed When a complaint is dismissed with prejudice, it cannot be refiled.. November…